Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hospital Location Advocate Condell Hospital Clinical Trial Description NSABP-51/RTOG1304-Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and PostLumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy Alliance 011202 trial will enroll patients who are not eligible for NSABP B-51/RTOG 1304 due to the presence of positive sentinel nodes after neoadjuvant chemotherapy. – Identification of Reasons Why Oncology patients Who Report Elevated Levels of Stress Decline Offers of Help and Resources Advocate Good Shepherd Hospital Identification of Reasons Why Oncology patients Who Report Elevated Levels of Stress Decline Offers of Help and Resources IRB # 6118 Quality of Life between group difference for internal vs. external locus of control in a cancer patient population. IRB#5307 Prospective Evaluation of CyberKnife as Monotherapy or Boost Stereotactic Body Radiotherapy (SBRT) for Intermediate or High Risk Localized Prostate Cancer Advocate Illinois Masonic Hospital CALGB 30610 (RTOG 0538) Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide RTOG 0534 Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed only Radiotherapy (SSPORT) in prostate Cancer Patients with a Rising PSA after Radical Prostatectomy RTOG 1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost versus Standard Whole Breast Irradiation Plus Sequential Boost for Early Stage Breast Cancer Phase III Prospective Randomized Trial of DoseEscalated Radiotherapy With or Without ShortTerm Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer RTOG 1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost versus Standard Whole Breast Irradiation Plus Sequential Boost for Early Stage Breast Cancer N0877: Phase I/Randomized Phase II Trial of either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM) Phase I/II Trial to Evaluate Accelerated Partial Breast Irradiation as Sole Radiation Treatment after Lumpectomy in Early Stage Breast Cancer Patients Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Identification of Reasons Why Oncology patients Who Report Elevated Levels of Stress Decline Offers of Help and Resources Phase III Intergroup Study of Temozolomide Alone Versus Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With EarlyStage Breast Cancer That Was Removed by Surgery NSABP PROTOCOL DMP-1: A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer Advocate Lutheran General Hospital GOG-0258: A RANDOMIZED PHASE III TRIAL OF CISPLATIN AND TUMOR VOLUME DIRECTED IRRADIATION FOLLOWED BY CARBOPLATIN AND PACLITAXEL VS. CARBOPLATIN AND PACLITAXEL FOR OPTIMALLY DEBULKED, ADVANCED ENDOMETRIAL CARCINOMA. GOG-0249: A PHASE III TRIAL OF PELVIC RADIATION THERAPY VERSUS VAGINAL CUFF BRACHYTHERAPY FOLLOWED BY PACLITAXEL/CARBOPLATIN CHEMOTHERAPY IN PATIENTS WITH HIGH RISK, EARLY STAGE ENDOMETRIAL CARCINOMA. Phase I/II Trial to Evaluate Accelerated Partial Breast Irradiation as Sole Radiation Treatment after Lumpectomy in Early Stage Breast Cancer Patients Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy. A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer Identification of Reasons Why Oncology patients Who Report Elevated Levels of Stress Decline Offers of Help and Resources Illinois Cyberknife at Advocate Lutheran General Hospital Prospective Evaluation of CyberKnife® as Monotherapy or Boost Stereotactic Body Radiotherapy (SBRT) for Intermediate or High Risk Localized Prostate Cancer: An Observational Study Prospective Evaluation of Low-Dose Irinotecan and Cyberknife Stereotactic Body Radiotherapy in the Treatment of Patients with Colorectal Cancer and Limited Liver Metastasis AMITA Health – Alexian Brothers B51 A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy